You must have meant April. People will lose there jobs in sales. Count on it. Reorganization coming next month.
FDA stopped approving me too products. Triple generic is a me too. You get a life and a brain. Idiot.
Blessing in disguise. The best thing to happen to DSI in a long time. Would have been a bust that cost the company millions. Morphabond won't be any better. Can't wait to sell a branded pain med in a generic market.
great point, look at how xareto and eliquis have failed in generic blood thinning market, and its not like people abuse pain killers at all so theres really no need, yure a natural marketer
Another idiot posting. Yeah a triple generic is the same thing as a factor xa can warfarin. I can't believe I work with these people.
Yeah, thank goodness it only cost SEVERAL HUNDRED MILLION DOLLARS in payments to Charleston Labs to get to this point, as well as a couple years of people resources. A little too optimistic from day 1. We could have squandered that money on other potential drugs that would have failed, darn!
yikes... so now with every thing being planned and rolled out for new quater and new year ... how many reps / managers do we need to market injectafer and morphabond ??? Maybe 1/2 of what was in Houston ? Also do we think AR managers and reps will be slashed first and DSI legacy employees given first dibs ? Lot to think about
This had to be the stupidest product idea I have ever seen. Anyone involved in purchased it or Morphabond has proven they are 100% out of touch with the world of 2017.